NATACHA MPILE: Open Payments
NPI 1538671532 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 28 payments from 18 companies in 2025. Trend: 2023 $453 · 2024 $449 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $83 |
| Astellas Pharma US Inc | 2 | $55 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| ABBVIE INC. | 2 | $37 |
| Boston Scientific Corporation | 1 | $36 |
| PFIZER INC. | 2 | $33 |
| Travere Therapeutics, Inc. | 1 | $32 |
| Amgen Inc. | 2 | $29 |
Products named: Veozah, SPRAVATO, ZEPBOUND, Kerendia, MOUNJARO, UBRELVY, BodyGuardian, FARXIGA.
Industry payments across GA — which companies pay providers there.
